Founded in 1981, Arthrex operates in medical device. No public ticker exists for the company.
Arthrex has no published valuation.
Arthrex is an orthopedic medical device manufacturer and developer of surgical equipment for arthroscopic and minimally invasive procedures. Founded in 1981 as Arthroscopy Excision Instruments Inc. by Reinhold Schmieding, the company was later renamed Arthrex Inc. and moved its headquarters to Naples, Florida in 1991. It distributes products to more than 90 countries and works with surgeons treating orthopedic injuries and arthritis.
Arthrex develops and releases more than 2,000 new products annually to advance minimally invasive orthopedics worldwide.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Arthrex.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Arthrex availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Arthrex included.
The routes section explains what is realistically available for a company at this stage.
No. Arthrex is a private company; its shares do not trade on a public exchange.
The closest medical device peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
